Clinical Trial: A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07463183) titled 'A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)' on March 04.

Brief Summary: The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per Modified Mayo Score at Week 12.

Study Start Date: March 30

Study Type: INTERVENTIONAL

Condition: Colitis Ulcerative Ulcerative Colitis

Intervention: DRUG: MK-8690

Solution for subcutaneou...